Page last updated: 2024-12-07

1-ethyl-2-benzimidazolinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Ethyl-2-benzimidazolinone (also known as 1-ethylbenzimidazol-2-one or EBI) is a heterocyclic compound that has been studied for its diverse range of biological activities. It is synthesized through a reaction of o-phenylenediamine with ethyl formate. EBI exhibits anti-inflammatory and analgesic effects, making it a potential candidate for treating inflammatory conditions. Research into EBI also explores its use as a corrosion inhibitor in various industrial applications. Its structure and properties make it an interesting subject for studying the relationship between chemical structure and biological activity.'

1-ethyl-2-benzimidazolinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID82320
CHEMBL ID452887
CHEBI ID34076
SCHEMBL ID612643
SCHEMBL ID7436460
SCHEMBL ID12397237
MeSH IDM0268616

Synonyms (57)

Synonym
HMS1779F03
EN300-24125
HMS3267A18
BB 0219700
ebio
gtpl2314
NCGC00024958-01
tocris-1041
1-ethyl-benzimidazolinone
1-ethylbenzimidazolin-2-one
einecs 233-148-1
1-ebio
10045-45-1
1-ethyl-2-benzimidazolinone
inchi=1/c9h10n2o/c1-2-11-8-6-4-3-5-7(8)10-9(11)12/h3-6h,2h2,1h3,(h,10,12
1-ethyl-1,3-dihydro-2h-benzimidazol-2-one
AKOS001213900
bdbm50275183
1-ethyl-1h-benzo[d]imidazol-2(3h)-one
chebi:34076 ,
CHEMBL452887 ,
3-ethyl-1h-benzimidazol-2-one
NCGC00024958-02
unii-m82w79ss4w
m82w79ss4w ,
0w8 ,
1-ethyl-2,3-dihydro-1h-1,3-benzodiazol-2-one
1-ethylbenzimidazolinone
1-eb10
FT-0636623
SCHEMBL612643
3-ethyl-2-benzimidazolinone
1-ethyl-1,3-dihydro-benzoimidazol-2-one
1-ethyl-1,3-dihydro-benzimidazol-2-one
2h-benzimidazol-2-one, 1-ethyl-1,3-dihydro-
SCHEMBL7436460
SCHEMBL12397237
HB1045
mfcd00005715
DTXSID70143296
J-000138
sr-01000597470
SR-01000597470-1
Z57114989
1-ebio, >=98% (hplc)
F16478
HMS3676A21
DS-17707
Q27077147
HMS3412A21
BRD-K70586315-001-01-6
3-ethyl-1h-benzimidazol-2-one.
E-150
A897436
2h-benzimidazol-2-one,1-ethyl-1,3-dihydro-
CS-0021217
HY-101360
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
imidazolesA five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
lethal factor (plasmid)Bacillus anthracis str. A2012Potency1.00000.020010.786931.6228AID912
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Small conductance calcium-activated potassium channel protein 3Rattus norvegicus (Norway rat)Ki50.00000.00182.13265.9000AID346945
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (28)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1346442Human KCa2.2 (Calcium- and sodium-activated potassium channels)2010Progress in neurobiology, Jul, Volume: 91, Issue:3
Small conductance calcium-activated potassium channels: from structure to function.
AID1346444Human KCa3.1 (Calcium- and sodium-activated potassium channels)2010Progress in neurobiology, Jul, Volume: 91, Issue:3
Small conductance calcium-activated potassium channels: from structure to function.
AID1346444Human KCa3.1 (Calcium- and sodium-activated potassium channels)2001The Journal of biological chemistry, Mar-30, Volume: 276, Issue:13
Control of electrical activity in central neurons by modulating the gating of small conductance Ca2+-activated K+ channels.
AID1346438Rat KCa2.2 (Calcium- and sodium-activated potassium channels)2001The Journal of biological chemistry, Mar-30, Volume: 276, Issue:13
Control of electrical activity in central neurons by modulating the gating of small conductance Ca2+-activated K+ channels.
AID1346463Rat KCa2.3 (Calcium- and sodium-activated potassium channels)2001Neuropharmacology, Jun, Volume: 40, Issue:7
Pharmacological modulation of SK3 channels.
AID1346449Human KCa2.1 (Calcium- and sodium-activated potassium channels)2010Progress in neurobiology, Jul, Volume: 91, Issue:3
Small conductance calcium-activated potassium channels: from structure to function.
AID1346449Human KCa2.1 (Calcium- and sodium-activated potassium channels)2001The Journal of biological chemistry, Mar-30, Volume: 276, Issue:13
Control of electrical activity in central neurons by modulating the gating of small conductance Ca2+-activated K+ channels.
AID1346444Human KCa3.1 (Calcium- and sodium-activated potassium channels)2000American journal of physiology. Cell physiology, Mar, Volume: 278, Issue:3
Pharmacological activation of cloned intermediate- and small-conductance Ca(2+)-activated K(+) channels.
AID1346452Human KCa2.3 (Calcium- and sodium-activated potassium channels)2004Molecular pharmacology, Mar, Volume: 65, Issue:3
An apamin- and scyllatoxin-insensitive isoform of the human SK3 channel.
AID1346452Human KCa2.3 (Calcium- and sodium-activated potassium channels)2010Progress in neurobiology, Jul, Volume: 91, Issue:3
Small conductance calcium-activated potassium channels: from structure to function.
AID1346438Rat KCa2.2 (Calcium- and sodium-activated potassium channels)2001The Journal of pharmacology and experimental therapeutics, Mar, Volume: 296, Issue:3
Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds.
AID1346442Human KCa2.2 (Calcium- and sodium-activated potassium channels)2005The Journal of biological chemistry, Dec-16, Volume: 280, Issue:50
Specific enhancement of SK channel activity selectively potentiates the afterhyperpolarizing current I(AHP) and modulates the firing properties of hippocampal pyramidal neurons.
AID1266425Induction of cardiogenesis in mouse CGR8 cells assessed as cardiac troponin positive cells measured on day 5 +10+2 EB-derived cells by flow cytometry analysis (Rvb = 11%)2015Journal of medicinal chemistry, Dec-24, Volume: 58, Issue:24
Medicinal Chemistry Approaches to Heart Regeneration.
AID1266417Induction of cardiogenesis in mouse embryonic stem cells assessed as enrichment of pacemaker like cardiomyocytes by patch clamp technique (Rvb = 7%)2015Journal of medicinal chemistry, Dec-24, Volume: 58, Issue:24
Medicinal Chemistry Approaches to Heart Regeneration.
AID1266418Induction of cardiogenesis in mouse embryonic stem cells assessed as enrichment of atrial like cardiomyocytes by patch clamp technique (Rvb = 7%)2015Journal of medicinal chemistry, Dec-24, Volume: 58, Issue:24
Medicinal Chemistry Approaches to Heart Regeneration.
AID1899309Induction of cell proliferation in postnatal day 6 rat cardiac cells assessed as stimulation in pro-prolierative responses2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation.
AID1266419Suppression of cardiogenesis in mouse embryonic stem cells assessed as ventricular like cardiomyocytes by patch clamp technique (Rvb = 86%)2015Journal of medicinal chemistry, Dec-24, Volume: 58, Issue:24
Medicinal Chemistry Approaches to Heart Regeneration.
AID1899340Pro-proliferative activity in CD1 mouse cardiac cells from P1 early postnatal developmental time points assessed as increases in cell number at at 0.33 to 10 uM2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation.
AID1899336Cytotoxicity against mouse Cardiomyocytes assessed as toxicity at > 1 uM2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation.
AID1899338Pro-proliferative activity in Wistar rat cardiac cells from P6 late postnatal developmental time points assessed as increases in cell number at at 0.33 to 10 uM2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation.
AID1899339Pro-proliferative activity in CD1 mouse cardiac cells from P6 late postnatal developmental time points assessed as increases in cell number at at 0.33 to 10 uM2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation.
AID346945Displacement of [I125]apamine from Wistar rat recombinant SK3 channel expressed in HEK293 cells2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators ofsmall conductance Ca2+-activated K+ channels.
AID346946Inhibition of Wistar rat recombinant SK3 channel expressed in HEK293 cells by whole cell patch clamp technique2008Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators ofsmall conductance Ca2+-activated K+ channels.
AID1899337Cytotoxicity against rat Cardiomyocytes assessed as toxicity at > 1 uM2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (125)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's14 (11.20)18.2507
2000's67 (53.60)29.6817
2010's38 (30.40)24.3611
2020's6 (4.80)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.17 (24.57)
Research Supply Index4.84 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.38%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other123 (97.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]